The study, supported by the National Institutes of Health, followed 377 patients receiving treatment at 21 centers in the U.S. The analysis found 22 percent of white adults received a heart transplant or ventricular assist device compared with only 11 percent of Black adults.
The findings underscore a possible racial bias in end-stage heart failure, according to an NIH release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
